Cargando…
Advances in the pharmaceutical treatment options for canine osteoarthritis
Canine osteoarthritis is a significant cause of pain in many dogs and can therefore compromise animal welfare. As the understanding of the biology and pain mechanisms underpinning osteoarthritis grows, so do the number of treatments available to manage it. Over the last decade, there have been a num...
Autores principales: | Pye, C., Bruniges, N., Peffers, M., Comerford, E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790257/ https://www.ncbi.nlm.nih.gov/pubmed/35285032 http://dx.doi.org/10.1111/jsap.13495 |
Ejemplares similares
-
Pharmaceutical Effects of Inhibiting the Soluble Epoxide Hydrolase in Canine Osteoarthritis
por: McReynolds, Cindy B., et al.
Publicado: (2019) -
Non‐pharmaceutical treatment options for meibomian gland dysfunction
por: Arita, Reiko, et al.
Publicado: (2020) -
New developments in osteoarthritis. Posttraumatic osteoarthritis: pathogenesis and pharmacological treatment options
por: Lotz, Martin K
Publicado: (2010) -
Nuclear magnetic resonance spectroscopy of biofluids for osteoarthritis
por: Clarke, Emily J, et al.
Publicado: (2020) -
Is Total Knee Arthroplasty a Viable Treatment Option in Octogenarians with Advanced Osteoarthritis?
por: Seo, Jai-Gon, et al.
Publicado: (2015)